Lisanne N. Manson

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.

Journal: EClinicalMedicine

Published: June 05, 2025

Reporting Adverse Drug Events: A Comparison of an Online Patient Tool Versus Telephone-Based Monitoring in Community Pharmacy Patients in the Netherlands.

Reporting Adverse Drug Events: A Comparison of an Online Patient Tool Versus Telephone-Based Monitoring in Community Pharmacy Patients in the Netherlands.

Journal: Drug safety

Published: May 23, 2025

Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.

Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.

Journal: Clinical pharmacology and therapeutics

Published: September 19, 2024

The association between the number of HLA risk alleles and drug allergy and its implications for HLA screening - a case-control study.

The association between the number of HLA risk alleles and drug allergy and its implications for HLA screening - a case-control study.

Journal: The pharmacogenomics journal

Published: July 11, 2024

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions.

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions.

Journal: Frontiers in genetics

Published: September 05, 2023

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs.

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs.

Journal: European journal of human genetics : EJHG

Published: August 11, 2023

The PREPARE study: benefits of pharmacogenetic testing are unclear - Authors' reply.

The PREPARE study: benefits of pharmacogenetic testing are unclear - Authors' reply.

Journal: Lancet (London, England)

Published: April 11, 2023

Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions.

Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions.

Journal: Frontiers in pharmacology

Published: October 04, 2022

Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis.

Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 29, 2021

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines.

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines.

Journal: Frontiers in pharmacology

Published: May 29, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026